A new collaborative project will make life science learning more accessible in the Nordics and give a boost to innovation and medical development.
The Nordic life science industry is booming and medical developments have never been this rapid. Nonetheless, in small countries like the Nordics, educational resources may not always be easy for the life science community to access. Now, five Nordic life science organisations from Sweden, Finland and Norway have joined forces to improve learning across borders. The organisations are Läkemedelsakademin and Läkemedelsindustriföreningen (LIF) from Sweden, Pharmaceutical Information Centre from Finland, and LMI – Legemiddelsindustrin and Oslo Cancer Cluster Incubator from Norway.
“Each of us are small countries, through this collaboration we can provide more high-quality learning opportunities for Life Science professionals and for a broader Nordic-Baltic target group, instead of reinventing the wheel,” says Hanna Rickberg, Head of Education at the Swedish Academy of Pharmaceutical Sciences.
As part of the Nordplus Horizontal programme, educational events, training workshops and practical courses directed towards the life science industry will be made available online. The life science professionals can participate via a live video stream or pre-recorded material, making learning accessible to those on-site or on remote locations and in other countries.
“Life science is a global business and cross-border collaboration is important, in particular for small countries in the Nordics,” says Bjørn Klem, general manager at Oslo Cancer Cluster Incubator.
Collaboration boosts innovations
The project has received support from Nordplus to facilitate the sharing of educational resources across national borders in the Nordics. This will act as an innovation boost to the Nordic life science environments.
“We are intrigued by the opportunity to explore how we can establish synergies across the Nordic markets when it comes to meeting educational needs within the Life Science sector. The underlying assumption is that the needs are similar. Networking for future collaboration may present as a secondary benefit,” says Dag Larsson, Senior Policy Manager, LIF – the Research Based Pharma Industry in Sweden.
Nordic cooperation will be paramount to make the most of medical advances and to make personalized medicine a reality.
“We see Nordic cooperation as an essential value to the medical development that is now taking place with both personalised medicine and building a life science industry across the Nordic countries,” says Marie Svendsen Aase, communications advisor Legemiddelindustrien (LMI).
The project will run until 30 April 2021 and the five partners will share their courses via their websites and social media channels.
“Nordplus collaboration provides us an excellent opportunity to expand our training services to the Nordic market and to share knowledge with the other partners,“ says Anja Isoaho, Training Manager at Pharmaceutical Information Centre (Finland).